Hidden drug reservoirs in cancer cells could explain treatment resistance

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...
KTTC

Mayo Clinic study finds lung cancer drug shows promise for ovarian cancer treatment

A discovery from Mayo Clinic researchers in Rochester shows a certain lung cancer treatment can also be used to treat ...
News Medical

Newfound role for PARP proteins could lead to therapeutic opportunities for cancer

Using technology they developed, UT Southwestern Medical Center researchers have identified a previously unknown role of a certain class of proteins: as regulators of gene activity and RNA processing.
EurekAlert!

MYC targeting by Omomyc synergizes with PARP inhibition and potentiates antitumor response in preclinical models of triple-negative breast cancer

Findings from a preclinical study led by VHIO’s Models of Cancer Therapies Group directed by Laura Soucek, an ICREA Research Professor and co-Founder and CSO of the VHIO and ICREA spin-off company ...
TMCnet

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that ...
UroToday

EAU 2026: How to Optimize Germline and Somatic Testing in Prostate Cancer?

HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR ...
Healthcare in Europe

“Hidden drug storehouses” could explain treatment resistance in cancer

One of oncology’s biggest challenges is that the same treatment can work well for some patients but fail completely in others ...